University Park, PA: Treatment admissions involving the use of heroin and other opioids decline following jurisdictions’ adoption of adult-use marijuana legalization, according to data published in the International Journal of Drug Policy.
Researchers affiliated with Pennsylvania State University assessed opioid-related treatment admission trends in states with and without marijuana legalization.
They identified lower rates of opioid misuse in adult-use legal states as compared to states without legalization and/or medical-only cannabis access.
The study’s authors concluded: “Across all 50 states from 1992 through 2023, evaluating cannabis liberalization as an accumulated policy pathway identified lower heroin involvement during both adult-use policy stages relative to continued no-policy status in the primary equal-state analysis. … The strongest evidence was for lower heroin involvement among reported TEDS [Treatment Episode Data Set] admissions during later adult-use policy stages relative to continued no-policy status. … This perspective builds on prior research showing that opioid-related estimates can differ across cannabis-policy stages.”
Observational studies have repeatedly determined that cannabis access laws are associated with reduced rates of opioid-abuse treatment admissions and mortality.
Full text of the study, “From medical authorization to adult-use retail: Cannabis policy stages and heroin involvement among US substance use treatment admissions,” appears in the International Journal of Drug Policy. Additional information is available from the NORML Fact Sheet, ‘Relationship Between Marijuana and Opioids.‘
